Literature DB >> 11572598

Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.

C Mischiati1, K T Jeang, G Feriotto, L Breda, M Borgatti, N Bianchi, R Gambari.   

Abstract

We have investigated the effects of aromatic polyamidines on HIV-1 transcription. We found a block to Tat-induced HIV-1 transcription assessed by inhibition of CAT activity in HL3T1 cells at a concentration lower than the IC50 value, suggesting that molecules with three (TAPB) and four (TAPP) benzamidine rings could be useful against HIV-1. In contrast, aromatic polyamidines with only two benzamidine rings (DAPP) did not block Tat-induced transcription. We reasoned that this effect could be due to binding of TAPB and TAPP to HIV-1 TAR RNA. By EMSA and filter binding assays, we studied possible interactions of aromatic polyamidines with HIV-1 TAR RNA. Wild-type TAR RNA or TAR RNA with mutations in the stem or bulge sequences, but retaining the stem-loop structure, was used to define the RNA-binding activities of these compounds. Our data suggest that aromatic polyamidines with two (DAPP) and four (TAPP) benzamidine rings, respectively, do not bind to TAR RNA or bind without sequence selectivity. Interestingly, an aromatic polyamidine with three benzamidine rings (TAPB) recognizes the wild-type TAR RNA in a specific manner. Furthermore, we found that introduction of one halogen atom into the benzamidine rings strongly increases the RNA-binding activity of these compounds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11572598     DOI: 10.1089/108729001317022214

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  9 in total

1.  Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates.

Authors:  Nihar Ranjan; Sunil Kumar; Derrick Watkins; Deyun Wang; Daniel H Appella; Dev P Arya
Journal:  Bioorg Med Chem Lett       Date:  2013-08-14       Impact factor: 2.823

2.  Tetra-O-4-methyl-phenyl-sulfonyl-penta-erythritol.

Authors:  Shu-Xian Li; Lin Zhu; Hoong-Kun Fun; Suchada Chantrapromma
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-07-12

3.  Multivalent binding oligomers inhibit HIV Tat-TAR interaction critical for viral replication.

Authors:  Deyun Wang; Jaclyn Iera; Heather Baker; Priscilla Hogan; Roger Ptak; Lu Yang; Tracy Hartman; Robert W Buckheit; Alexandre Desjardins; Ao Yang; Pascale Legault; Venkat Yedavalli; Kuan-Teh Jeang; Daniel H Appella
Journal:  Bioorg Med Chem Lett       Date:  2009-10-23       Impact factor: 2.823

4.  TAR-RNA recognition by a novel cyclic aminoglycoside analogue.

Authors:  Devanathan Raghunathan; Víctor M Sánchez-Pedregal; Jochen Junker; Claudia Schwiegk; Markus Kalesse; Andreas Kirschning; Teresa Carlomagno
Journal:  Nucleic Acids Res       Date:  2006-07-19       Impact factor: 16.971

Review 5.  Molecular strategies to inhibit HIV-1 replication.

Authors:  Morten Hjuler Nielsen; Finn Skou Pedersen; Jørgen Kjems
Journal:  Retrovirology       Date:  2005-02-16       Impact factor: 4.602

6.  Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.

Authors:  Emmanuel T Agbottah; Christine Traviss; James McArdle; Sambhav Karki; Georges C St Laurent; Ajit Kumar
Journal:  Retrovirology       Date:  2007-06-12       Impact factor: 4.602

7.  Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat.

Authors:  Julie K Jadlowsky; Masanori Nojima; Antje Schulte; Matthias Geyer; Takashi Okamoto; Koh Fujinaga
Journal:  Retrovirology       Date:  2008-07-11       Impact factor: 4.602

8.  Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.

Authors:  Guillaume Mousseau; Susana Valente
Journal:  Biology (Basel)       Date:  2012-11-19

9.  Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.

Authors:  Megan L Kelly; Chia-Chieh Chu; Honglue Shi; Laura R Ganser; Hal P Bogerd; Kelly Huynh; Yuze Hou; Bryan R Cullen; Hashim M Al-Hashimi
Journal:  RNA       Date:  2020-10-07       Impact factor: 5.636

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.